Logo image of APLM

APOLLOMICS INC (APLM) Stock Overview

NASDAQ:APLM - KYG0411D1236 - Common Stock

5.75 USD
+0.23 (+4.17%)
Last: 9/9/2025, 4:30:01 PM

APLM Key Statistics, Chart & Performance

Key Statistics
52 Week High35.98
52 Week Low3.66
Market Cap6.33M
Shares1.10M
Float700.00K
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.93
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO11-26 2021-11-26
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


APLM short term performance overview.The bars show the price performance of APLM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20

APLM long term performance overview.The bars show the price performance of APLM in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of APLM is 5.75 USD. In the past month the price increased by 1.05%. In the past year, price decreased by -57.72%.

APOLLOMICS INC / APLM Daily stock chart

APLM Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.87 371.72B
AMGN AMGEN INC 12.84 150.72B
GILD GILEAD SCIENCES INC 14.96 143.64B
VRTX VERTEX PHARMACEUTICALS INC 23.4 101.65B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 63.20B
REGN REGENERON PHARMACEUTICALS 12.19 58.99B
ARGX ARGENX SE - ADR 82.74 46.94B
ONC BEONE MEDICINES LTD-ADR 6.15 41.74B
INSM INSMED INC N/A 31.11B
BNTX BIONTECH SE-ADR N/A 24.54B
NTRA NATERA INC N/A 24.21B
BIIB BIOGEN INC 8.97 21.05B

About APLM

Company Profile

APLM logo image Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company is headquartered in Foster City, California and currently employs 13 full-time employees. The company went IPO on 2021-11-26. The product candidates in its pipeline are categorized into two groups based on their mechanisms of action, each of which contains product candidates at different stages of development: tumor inhibitors and immuno-oncology drugs. Its tumor inhibitor product candidates consist of three small-molecule inhibitors against different uncontrolled growth signaling pathways in cancer cells: vebreltinib, APL-102 and APL-122. Its three immuno-oncology product candidates consist of APL-501, APL-502 and APL-80. Vebreltinib is a potent, oral active selective c-Met inhibitor. APL-102 is an oral active, small molecule Multiple Tyrosine Kinase Inhibitor. APL-122 is a tumor inhibitor candidate, targeting ErbB1/2/4 signaling pathways. APL-501 is an anti-PD-1 antibody product candidate.

Company Info

APOLLOMICS INC

989 East Hillsdale Blvd, Ste 220

Foster City CALIFORNIA US

Employees: 13

APLM Company Website

APLM Investor Relations

Phone: 16502094055

APOLLOMICS INC / APLM FAQ

What is the stock price of APOLLOMICS INC today?

The current stock price of APLM is 5.75 USD. The price increased by 4.17% in the last trading session.


What is the ticker symbol for APOLLOMICS INC stock?

The exchange symbol of APOLLOMICS INC is APLM and it is listed on the Nasdaq exchange.


On which exchange is APLM stock listed?

APLM stock is listed on the Nasdaq exchange.


What is APOLLOMICS INC worth?

APOLLOMICS INC (APLM) has a market capitalization of 6.33M USD. This makes APLM a Nano Cap stock.


How many employees does APOLLOMICS INC have?

APOLLOMICS INC (APLM) currently has 13 employees.


What are the support and resistance levels for APOLLOMICS INC (APLM) stock?

APOLLOMICS INC (APLM) has a resistance level at 5.95. Check the full technical report for a detailed analysis of APLM support and resistance levels.


Is APOLLOMICS INC (APLM) expected to grow?

The Revenue of APOLLOMICS INC (APLM) is expected to decline by -100% in the next year. Check the estimates tab for more information on the APLM EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy APOLLOMICS INC (APLM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does APOLLOMICS INC (APLM) stock pay dividends?

APLM does not pay a dividend.


What is the Price/Earnings (PE) ratio of APOLLOMICS INC (APLM)?

APOLLOMICS INC (APLM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.93).


What is the Short Interest ratio of APOLLOMICS INC (APLM) stock?

The outstanding short interest for APOLLOMICS INC (APLM) is 2% of its float. Check the ownership tab for more information on the APLM short interest.


APLM Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to APLM. When comparing the yearly performance of all stocks, APLM is a bad performer in the overall market: 93.47% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

APLM Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to APLM. Both the profitability and financial health of APLM have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

APLM Financial Highlights

Over the last trailing twelve months APLM reported a non-GAAP Earnings per Share(EPS) of -1.93. The EPS decreased by -3757.18% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -311.63%
ROE -418.59%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-3757.18%
Revenue 1Y (TTM)N/A

APLM Forecast & Estimates

For the next year, analysts expect an EPS growth of 99.53% and a revenue growth -100% for APLM


Analysts
Analysts82.86
Price TargetN/A
EPS Next Y99.53%
Revenue Next Year-100%

APLM Ownership

Ownership
Inst Owners0.22%
Ins Owners20.62%
Short Float %2%
Short Ratio0.38